Missouri Delta Medical Center Partners with CureMetrix to Enhance Mammography Using AI
Missouri Delta Medical Center teams up with CureMetrix to implement AI-enhanced mammography, improving early breast cancer detection and becoming Missouri's first facility to offer AI-enabled breast arterial calcification detection.
- • Missouri Delta partners with CureMetrix for AI-powered mammography enhancement.
- • The AI technology focuses on detecting breast arterial calcifications to aid early breast cancer detection.
- • Missouri Delta is the first in Missouri to use AI for BAC detection in routine mammograms.
- • CureMetrix's President Kevin Harris and Missouri Delta's CEO Jason Schrumpf emphasize the health impact and innovation benefits of the partnership.
Key details
Missouri Delta Medical Center in Sikeston, Missouri, has partnered with AI imaging service provider CureMetrix to integrate advanced artificial intelligence into their mammography services. This collaboration aims to improve early detection of breast cancer by utilizing AI technology that assists in identifying breast arterial calcifications (BAC), a key indicator in breast health diagnostics. According to Kevin Harris, President of CureMetrix, the partnership reflects a strong commitment to innovation and improving women’s health outcomes. Missouri Delta is the first health system in Missouri to offer AI-enabled BAC detection as part of its routine mammography exams. Jason Schrumpf, CEO of Missouri Delta Medical Center, described this partnership as a "game-changer" for women’s health in the region, highlighting the dual benefit of more comprehensive screening capabilities that AI integration provides. This initiative underscores a significant advancement in applying artificial intelligence to enhance breast cancer screening precision and early intervention efforts.